PitchSend

Investor Presentaiton

30 China Market Dynamics ■China has paved the way for integration with global standard and move up to key positions in value chain, requiring dedication to quality and innovation Tightened GMP, Environment/Health/Safety laws and drug license approval process significantly raise the cost structure ■Full Market Authorization Holder (MAH) rolled out creating a sizable demand in high-quality CDMO services. ■Reduction of application backlog and review timeline acceleration for NDA and China+US dual-track drug filing ScinoPharm

View entire presentation